"Is RHY too late to the party?"
I don't think so. The clinical trials required to prove that 8 different cancers can be detected and identified in their early stages will be hellishly complex. It's really ambitious, although I hope of course for all our sakes they have success. And then there's the cost, they are estimating $500 per test.
Meanwhile RHY are targetting bowel cancer in isolation. My feeling is they can get a cheaper and better product to market faster than this lot, especially with the progress thay have already made and with the backing of the CSIRO.
Anyway, I hope I am right!
"Is RHY too late to the party?" I don't think so. The clinical...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RHY (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.41M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5969 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 5500 | 1 |
View Market Depth
| Last trade - 16.16pm 18/11/2024 (20 minute delay) ? |
| RHY (ASX) Chart |
Day chart unavailable
